Altimmune Inc (ALT) support and resistance · rev $20.0K
Altimmune Inc (ALT) is a biotechnology company listed on US.
This page maps Altimmune Inc (ALT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
ALT currently screens at market cap $527.0M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ALT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ALT quote page for the session range and the stock page for the full model.
Not investment advice.